登录后查看消息通知
搜索
常见问题
消息
登录
首页
/
数据集
/
Subgroup analysis: OS and DFS in study patients.
Subgroup analysis: OS and DFS in study patients.
收藏
Figshare
2017-10-18 更新
2026-04-29 收录
肿瘤临床试验
生存期亚组分析
数据链接:
https://figshare.com/articles/dataset/Subgroup_analysis_OS_and_DFS_in_study_patients_/5507167
数据链接
链接失效反馈
官方服务:
问题咨询
购买咨询
在线客服
NEW
资源简介:
Subgroup analysis: OS and DFS in study patients.
应用场景:
创建时间:
2017-10-18
相关数据集
Supplementary Table S3 from Safety and Efficacy of Anlotinib Hydrochloride Plus Temozolomide in Patients with Recurrent Glioblastoma
肿瘤临床试验
药物联合疗法评估
Supplementary Table S3. Summary of other trial results for recurrent glioblastoma.
Figshare
2023-10-02 更新
6
0
Treatment of Childhood Nasopharyngeal Carcinoma With Neoadjuvant Chemotherapy and Concomitant Chemoradiotherapy: A Groupwide Phase III Study
儿童鼻咽癌治疗
肿瘤临床试验
This phase III trial is studying how well radiation therapy, amifostine, and chemotherapy work in treating young patients with newly diagnosed nasopharyngeal cancer. Radiation therapy uses high-ener
DataCite Commons
2025-06-01 更新
4
0
Median OS, median PFS, sample size, and total number number of deaths based on the RECORD-1 trial.
肿瘤临床试验
生存分析
Median OS, median PFS, sample size, and total number number of deaths based on the RECORD-1 trial.
Figshare
2021-11-15 更新
3
0
Second-line treatment of metastatic colorectal cancer with HR070803 in combination with 5-FU/LV and BP102
肿瘤临床试验
药物疗效评估
Interventions: experimental group:HR0708035, FU/LV and BP102 Primary outcome(s): Objective response rate Study Design: Single arm
NIAID Data Ecosystem
4
0
Trial patient and tumour characteristics.
肿瘤临床试验
患者特征分析
Trial patient and tumour characteristics.
Figshare
2018-03-29 更新
3
0
© 2023-2026 上海数据发展科技有限责任公司 版权所有
沪ICP备17003045号-15
沪公网安备31010402336585号
热门搜索
社区交流群
科研交流群
商业服务
数据资源
寻源服务
数据采集
标注服务
数据产品
代理销售
数据领域
凭证登记
数据产品
介绍推广